Skip to main content

Table 1 Patient demographics. sd, standard deviation; \(R_{0}\), negative margin; \(R_{1-2}\), positive margin with tumor cells in the inked surface of the resection margin; MFH/UPS/NOS, alignant fibrous histiocytoma / undifferentiated pleomorphic sarcoma / (pleomorphic) soft tissue sarcomas not-otherwise-specified; histology “Other”, angiosarcoma, clear cell sarcoma, conventional fibrosarcoma, epithelioid sarcoma, giant cell sarcoma, malignant granular cell tumor, malignant peripheral nerve sheath tumor, rhabdomyosarcoma (adult form), spindle cell sarcoma, unclassified soft tissue sarcoma and undifferentiated sarcoma

From: Statistical models versus machine learning for competing risks: development and validation of prognostic models

Characteristics

Total (N = 3826)

Gender (%)

 

    Female

1713 (44.77%)

    Male

2113 (55.23%)

Mean age in years (sd)

59.40 (18.04)

Mean tumor size in cm (sd)

8.97 (5.69)

Surgical margin (%)

 

    \(R_{0}\)

3310 (86.51%)

    \(R_{1-2}\)

516 (13.49%)

Adjuvant chemotherapy (%)

 

    No

3350 (87.56%)

    Yes

476 (12.44%)

Tumor grade (%)

 

    II

656 (17.15%)

    III

3170 (82.85%)

Histological subtype (%)

 

    Myxofibrosarcoma

771 (20.15%)

    Synovial sarcoma

450 (11.76%)

    MFH/UPS/NOS

1330 (34.76%)

    Leiomyosarcoma

385 (10.06%)

    Liposarcoma

421 (11.00%)

    Other

469 (12.26%)

Tumor depth (%)

 

    Superficial

1014 (26.50%)

    Deep

2812 (73.50%)

Radiotherapy (%)

 

    No

1341 (35.05%)

    Neoadjuvant

521 (13.62%)

    Adjuvant

1964 (51.13%)